Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Serono Serostim Counterfeits May Have Originated In Asia, FDA Says

Executive Summary

Counterfeit versions of Serono's Serostim recently found in the U.S. may have originated in Asia, FDA Senior Associate Commissioner for Policy, Planning & Legislation William Hubbard told the Senate Commerce/Consumer Affairs Subcommittee Sept. 5.

You may also be interested in...



Rx Reimportation Bill In Senate Will Focus On Canada, Sen. Dorgan Says

Prescription drug reimportation advocates in the Senate are focusing on a Canada-only approach for 2001.

Rx Reimportation Bill In Senate Will Focus On Canada, Sen. Dorgan Says

Prescription drug reimportation advocates in the Senate are focusing on a Canada-only approach for 2001.

Serono Serostim

Counterfeit Serostim has been reported by 10 to 12 patients, primarily in California. The only reported adverse reaction by patients who had injected the counterfeit product was skin irritation at the injection site, the company said. FDA's Office of Criminal Investigations is attempting to determine the distributor of the fake product. Somatropin is approved for AIDS wasting

UsernamePublicRestriction

Register

OM017301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel